Certara Chief Commercial Officer Ellen Leinfuss said the company’s scientists and modelers have been using the workbench – Pirana – for years.
“We see the great potential to expand on Pirana’s core value through increased connectivity with other pharmacometric tools, including Phoenix,” she told us.
Developed by Ron Keizer, PhD, in 2007, Pirana is a pharmacometrics workbench providing structure, tools, and a graphical user interface create pharmacometric models and perform simulations.
“This is critical as today’s modeling and simulation analyses are often large and complex, requiring extreme diligence in organizing, visualizing and communicating results and decision-making recommendations,” Leinfuss explained.
“Additionally, traceability and reproducibility are pivotal to validating modeling results, and are key to Pirana’s value proposition,” she said.
Certara’s Phoenix desktop software for pharmacokinetic (PK), pharmacodynamic (PD) and toxicokinetic modeling and simulation is used by 6,000 researchers at 1,500 biopharmaceutical companies and academic institutions in 60 countries.
It also is employed by many global regulatory agencies, including 11 divisions of the US Food and Drug Administration (FDA).
Certara today launched the BaseCase Portal, which it said allows life sciences companies to deploy mobile apps to health care providers (HCPs) at the point of care.
“The new product offering from BaseCase provides a white label portal for life sciences companies to leverage with their users, most especially HCPs," Leinfuss told us.
According to the company, customizable mobile apps connect to mathematical models and algorithms to help HCPs optimize patient treatment.
The apps can be used for various purposes in addition to supporting point of care decision making, providing information (educational or product information), as well as enabling collaboration.
"A key component of BaseCase Portal is the opportunity to release a 'package' of different language versions of apps that have been translated and labeled by region and therapeutic area," said Leinfuss.
The launch follows Certara’s acquisition of the software as a service (SaaS) company in January 2018.